Groowe Groowe BETA / Newsroom
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

Vor Bio to Participate in Upcoming Investor Conferences

globenewswire.com
VOR Vor Bio is mentioned in the context of investor conferences, but the provided text does not indicate a clear market sentiment.

BOSTON, Nov. 07, 2025 (GLOBE NEWSWIRE) -- Vor Bio (Nasdaq: VOR), a clinical-stage biotechnology company transforming the treatment of autoimmune diseases, today announced that it will participate in the following upcoming investor conferences:

TD Cowen Virtual Immunology & Inflammation Summit

Fireside Chat: Wednesday, November 12, 2025, at 2:30pm ET

8th Annual Evercore Healthcare Conference

Fireside Chat: Tuesday, December 2, 2025, 3:00pm ET

Location: Miami, FL

A live webcast and archived replay of the fireside chats will be available on the investors section of www.vorbio.com.

About Vor Bio

Vor Bio is a clinical-stage biotechnology company transforming the treatment of autoimmune diseases. The Company is focused on rapidly advancing telitacicept, a novel dual-target fusion protein, through Phase 3 clinical development and potential commercialization to address serious autoantibody-driven conditions worldwide. For more information visit www.vorbio.com.

Media & Investor Contacts:

Carl Mauch

cmauch@vorbio.com

Sarah Spencer

investors@vorbio.com